Literature DB >> 11059998

Effects of cognitive therapy on psychological symptoms and social functioning in residual depression.

J Scott1, J D Teasdale, E S Paykel, A L Johnson, R Abbott, H Hayhurst, R Moore, A Garland.   

Abstract

BACKGROUND: About 30% of psychiatric out-patients with major depression demonstrate partial remission. AIMS: To explore whether the addition of cognitive therapy (CT) had any differential effect on residual symptoms or social adjustment.
METHOD: Patients with residual symptoms of major depression (n=158) were randomised to receive clinical management (CM) alone, or CM plus 18 sessions of CT. Subjects' depressive symptoms and social functioning were assessed regularly over 16 months.
RESULTS: The addition of CT produced statistically significant differential effects on: two out of four measures of overall severity of depression; specific psychological symptoms (guilt, self-esteem and hopelessness); and social functioning (including dependency, interpersonal behaviour and friction).
CONCLUSIONS: In patients showing only partial response to antidepressants, the addition of CT produced modest improvements in social and psychological functioning. The implications for research on the mechanisms of action of CT are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11059998     DOI: 10.1192/bjp.177.5.440

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  16 in total

1.  Specific treatment of residual fatigue in depressed patients.

Authors:  Humberto Marin; Matthew A Menza
Journal:  Psychiatry (Edgmont)       Date:  2004-09

Review 2.  Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.

Authors:  Ranak B Trivedi; Jason A Nieuwsma; John W Williams
Journal:  J Gen Intern Med       Date:  2010-12-24       Impact factor: 5.128

Review 3.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

4.  Treatment of depressed mothers in home visiting: impact on psychological distress and social functioning.

Authors:  Robert T Ammerman; Frank W Putnam; Mekibib Altaye; Angelique R Teeters; Jack Stevens; Judith B Van Ginkel
Journal:  Child Abuse Negl       Date:  2013-04-25

5.  Reductions in stress and depressive symptoms in mothers of substance-exposed infants, participating in a psychosocial program.

Authors:  Janet K Kern; Emily Y West; Bruce D Grannemann; Tracy L Greer; Laura M Snell; Lori L Cline; Toosje T VanBeveren; Stephen F Heartwell; Beverly A Kleiber; Madhukar H Trivedi
Journal:  Matern Child Health J       Date:  2004-09

6.  Feasibility of dissemination of cognitive behavioral therapy to Texas community mental health centers.

Authors:  Molly A Lopez; Monica Ramirez Basco
Journal:  J Behav Health Serv Res       Date:  2011-01       Impact factor: 1.505

7.  Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.

Authors:  Miki Matsunaga; Yasumasa Okamoto; Shin-ichi Suzuki; Akiko Kinoshita; Shinpei Yoshimura; Atsuo Yoshino; Yoshihiko Kunisato; Shigeto Yamawaki
Journal:  BMC Psychiatry       Date:  2010-03-16       Impact factor: 3.630

Review 8.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.

Authors:  Patrick E McKnight; Todd B Kashdan
Journal:  Clin Psychol Rev       Date:  2009-02-07

9.  Improvement in social-interpersonal functioning after cognitive therapy for recurrent depression.

Authors:  J R Vittengl; L A Clark; R B Jarrett
Journal:  Psychol Med       Date:  2004-05       Impact factor: 7.723

10.  Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

Authors:  David Brent; Graham Emslie; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Marty Keller; Benedetto Vitiello; Louise Ritz; Satish Iyengar; Kaleab Abebe; Boris Birmaher; Neal Ryan; Betsy Kennard; Carroll Hughes; Lynn DeBar; James McCracken; Michael Strober; Robert Suddath; Anthony Spirito; Henrietta Leonard; Nadine Melhem; Giovanna Porta; Matthew Onorato; Jamie Zelazny
Journal:  JAMA       Date:  2008-02-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.